Category Archives: Disease

Join a clinical trial? The success rate of such trials is higher than you thought, but still awfully low overall; especially for Alzheimer’s.

The News: Instead of less than 10% of drugs reaching the market, a new study has found that almost 15% of new compounds pass clinical trial–which still suggests that it’s… Read more »

Investor Alert: Qiagen grabs Spanish biotech STAT-Dx in quest for new and better diagnostic tests. My personal take.

The News: Molecular diagnostics company Qiagen NV (Hilden DEU) has agreed to acquire biotech STAT-Dx SL (Barcelona) for up to €153 million–over 3 times the total funding the Spanish company has raised… Read more »

Investor alert: Pear Therapeutics hauls-in $50 million Series B after FDA clears first-ever mobile app for substance abuse therapy. What would Warren Buffet think?

The News: The US Food and Drug Administration (FDA) recently cleared for marketing the first prescription mobile medical application to help treat substance use disorders (SUDs) involving alcohol, cocaine, marijuana,… Read more »

Boomer Alert: You need not die from metastatic prostate cancer. Breakthrough findings point to new treatment approach.

The News: Obesity is linked to prostate cancer, scientists know, but it’s not been clear-cut why. Last week, however, researchers reported a surprising connection. When prostate cancers lose a particular… Read more »

Two European Parkinson’s studies kick off 2018 with promising discoveries; proof to me, for example, that not all biotech worth noting come from the USA.

The News: A combination therapy made up of two neurotrophic factors has been shown in a report to reduce the degenerative effects of Parkinson’s disease, report researchers from the UPV/EHU-University… Read more »

Ablynx soars 60% on Novo’s latest hostile bid; grab a piece of this Belgian biotech because the real action’s just starting.

The News: Denmark’s Novo Nordisk A/S (Copenhagen), the world’s biggest insulin maker, went public Monday (January 8, 2018) with a €2.6-billion ($3.1 billion) bid for Belgian biotech group Ablynx NV… Read more »

Study says defibrillator drones could save countless lives before ambulance eventually arrives. Seems obvious, but what happened to good-old CPR?

The News:  The speed of unmanned aerial systems, commonly called drones, could save lives, since for every minute that passes between cardiac arrest and CPR or defibrillation, the chance of… Read more »

Boomer anti-aging alert: study says eating leafy greens daily makes you 11 years younger, cognitively.

The News: While cognitive abilities naturally decline with age, eating one serving of leafy green vegetables a day may aid in preserving memory and thinking skills as a person grows… Read more »

Micro biotech Alzinova, hiding out in southwest Sweden, using proprietary peptide technology that targets key Alzheimer’s toxins.

Background: Alzinova AB (Gothenburg) is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer’s disease (AD). The company was founded in 2011… Read more »